A scored form of the Bristol Female Lower Urinary Tract Symptoms questionnaire: Data from a randomized controlled trial of surgery for women with stress incontinence

Brookes, Sara; Donovan, Jenny; Wright, Melissa; Jackson, Sonia; Abrams, Paul

doi:10.1016/j.ajog.2003.12.027

Cited by 238 publications

(148 citation statements)

References 8 publications

Supporting

Mentioning

140

Contrasting

Unclassified

Order By: Relevance

“…a The ICIQ-FLUTS version provided by the ICIQ group, and currently available on their website (v08/04), is scored out of 48 as indicated in the table; the scored form of this questionnaire was scored out of 47. 43 The difference relates to the categorisation of frequency of daytime micturition. The authors sought advice from the ICIQ group jointly, and from the individual authors of the cited publication, on how best to score v08/04, but received no useful response.…”

Section: Appendix 3 General Practitioner Notification Of Recruitmentmentioning

confidence: 99%

See 1 more Smart Citation

INVESTIGATE-I (INVasive Evaluation before Surgical Treatment of Incontinence Gives Added Therapeutic Effect?): a mixed-methods study to assess the feasibility of a future randomised controlled trial of invasive urodynamic testing prior to surgery for stress urinary incontinence in women

Hilton

Armstrong

Brennand

et al. 2015

Health Technology Assessment

View full text Add to dashboard Cite

BackgroundThe position of invasive urodynamic testing in the diagnostic pathway for urinary incontinence (UI) is unclear. Systematic reviews have called for further trials evaluating clinical utility, although a preliminary feasibility study was considered appropriate.ObjectivesTo inform the decision whether or not to proceed to a definitive randomised trial of invasive urodynamic testing compared with clinical assessment with non-invasive tests, prior to surgery in women with stress UI (SUI) or stress predominant mixed UI (MUI).DesignA mixed-methods study comprising a pragmatic multicentre randomised pilot trial; economic evaluation; survey of clinicians’ views about invasive urodynamic testing; qualitative interviews with clinicians and trial participants.SettingUrogynaecology, female urology and general gynaecology units in Newcastle, Leicester, Swansea, Sheffield, Northumberland, Gateshead and South Tees.ParticipantsTrial recruits were women with SUI or stress predominant MUI who were considering surgery after unsuccessful conservative treatment. Relevant clinicians completed two online surveys. Subsets of survey respondents and trial participants took part in separate qualitative interview studies.InterventionsPilot trial participants were randomised to undergo clinical assessment with non-invasive tests (control arm); or assessment as controls, plus invasive urodynamic testing (intervention arm).Main outcome measuresConfirmation that units can identify and recruit eligible women; acceptability of investigation strategies and data collection tools; acquisition of outcome data to determine the sample size for a definitive trial. The proposed primary outcome for the definitive trial was International Consultation on Incontinence Modular Questionnaire (ICIQ) Female Lower Urinary Tract Symptoms (ICIQ-FLUTS) (total score) 6 months after surgery or the start of non-surgical treatment; secondary outcomes included: ICIQ-FLUTS (subscales); ICIQ Urinary Incontinence Short Form; ICIQ Lower Urinary Tract Symptoms Quality of Life; Urogenital Distress Inventory; EuroQol-5D; costs, quality-adjusted life-years (QALYs) and incremental cost per QALY, Short Form 12; 3-day bladder diary.ResultsOf 284 eligible women, 222 (78%) were recruited; 165/219 (75%) returned questionnaires at baseline and 125/200 (63%) who were sent questionnaires at follow-up. There were few missing data items in returned questionnaires, with individual outcome scales calculable for 81%–94%. Most women underwent surgery; management plans were changed in 19 (19%) participants following invasive urodynamic testing. Participant Costs Questionnaires were returned by 53% 6 months after treatment; complete data to undertake cost–utility analysis were available in 27% (intervention) and 47% (control). While insufficient to recommend changes in practice, the results suggest further research would be valuable. All clinicians responding to the survey had access to invasive urodynamic testing, and most saw it as essential prior to surgery in women with SUI with or without other symptoms; nevertheless, 70% considered the research question underlying INVESTIGATE important and most were willing to randomise patients in a definitive trial. Participants interviewed were positive about the trial and associated documentation; the desire of some women to avoid invasive urodynamic testing contrasted with opinions expressed by clinicians through both survey and interview responses.ConclusionsAll elements of a definitive trial and economic evaluation were rehearsed; several areas for protocol modification were identified. Such a trial would require to 400–900 participants, depending on the difference in primary outcome sought.Future workA definitive trial of invasive urodynamic testing versus clinical assessment prior to surgery for SUI or stress predominant MUI should be undertaken.Trial registrationCurrent Controlled Trials ISRCTN71327395.FundingThe National Institute for Health Research Health Technology Assessment programme.

show abstract

Section: Appendix 3 General Practitioner Notification Of Recruitmentmentioning

confidence: 99%

“…43 Secondary outcomes for the future trial, also rehearsed in the pilot, comprise: l EuroQol-5D (EQ-5D)-3 Level (EQ-5D-3L). 67 l utility values from the EQ-5D-3L and from Short Form 6D (SF-6D) [the latter derived from responses to the Short Form 12 (SF-12)].…”

Section: Outcome Measuresmentioning

confidence: 99%

INVESTIGATE-I (INVasive Evaluation before Surgical Treatment of Incontinence Gives Added Therapeutic Effect?): a mixed-methods study to assess the feasibility of a future randomised controlled trial of invasive urodynamic testing prior to surgery for stress urinary incontinence in women

Hilton

Armstrong

Brennand

et al. 2015

Health Technology Assessment

View full text Add to dashboard Cite

show abstract

“…Bu anketin skorlanmış formu (BFLUTS-SF) kadınlarda üriner inkontinansı, yaşam kalitesini ve aşırı aktif mesaneyi değerlendirmede geçerli, güvenilir ve tekrarlanabilir bir test olarak kabul edilmişken ölçülebilir bir form olmayan BFLUTS'un BFLUTS-SF'in aksine yaşam kalitesini değerlendirmede yetersiz kalabileceği bildirilmiştir. BFLUTS-SF; 4 soruluk (BFLUTS-FS (dolum semptomları), 3 soruluk BFLUTS-VS (işeme semptomları), 5 soruluk BFLUTS-IS (inkontinans semptomları), 2 soruluk BFLUTS-sex (cinsel fonksiyonlar) ve 5 soruluk BFLUTS-QoL (yaşam kalitesi) şeklinde 5 soru kategorisi üzerinden toplam 19 soru olarak dizayn edilmiştir [19,20]. BFLUTS formu daha eski ve dolayısıyla daha uzun süredir kullanılır olduğundan bu formun kullanıldığı daha çok çalışma vardır.…”

Section: Discussionunclassified

“…Aynı çalışmada koital inkontinans ve ağrının stres inkontinanslı kadınlarda aşırı aktif mesaneli kadınlardan daha sık olduğunu belirtmişlerdir [22]. Brookes ve arkadaşları stres inkontinans nedeniyle cerrahi uygulanan kadınlarda semptomların hayat kalitesine etkilerini araştırdıkları bir çalışmada BFLUTS formu kullanmışlar ve bu anket formunun üroloji ve jinekoloji pratiğinde kullanılması gereken faydalı ve yeni bir test olduğunu belirtmişlerdir [19]. Aksakal ve arkadaşlarının 2006 yılında stres inkontinansta transobturator tape tedavisinin sonuçlarını değerlendirdikleri çalışmalarında BFLUTS formunu (Türkçe geçerliliği yapılmamış haliyle) kullanmışlardır.…”

Section: Discussionunclassified

Validation of Turkish Version of Bristol Female Lower Urinary Tract Symptom Index

2012

Ann Clin Anal Med

View full text Add to dashboard Cite

BFLUTS questionnaire were filled by the patients 2 times with a six-week interval. The self-consistency and reliability of the test were evaluated by Cronbach's alpha coefficient and test re-test correlation coefficients, respectively. Results: Cronbach's alpha coefficient was calculated to be 0.931 for all the questions, indicating that the questions were consistent with each other. The correlation coefficient for the test at day 0 and 6 weeks was 0.821 (p<0.001). This result indicated that the questions were clearly understood by the patients, and the same or similar answers were given to the same questions at different times. Discussion: The current Turkish version of BFLUTS index questionnaire can be used in the urological daily practice as it is a valid and consistent tool for the evaluation of female urinary incontinence and its impacts on sexual function and quality of life.

show abstract

“…5 The BF-LUTS score quantifies symptoms of incontinence along with their impact on sexual function and quality of life that are not commonly included in other female questionnaires. It includes variables like incontinence (I -5 items); voiding (V-3 items); and filling (F-4 items); with additional subscales for sexual function (S-2 items) and quality of life issue (QoL-5 items).…”

Section: Methodsmentioning

confidence: 99%

Association of metabolic syndrome and lower urinary tract symptoms amongst South Indian postmenopausal women

Kamaraj¹,

Londhe²,

Shetty³

et al. 2017

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

Background: Women spend one third of their life in menopause. The age related anatomical and physiological changes predispose them to MetS and lower urinary tract symptoms (LUTS). The aim was to study the prevalence of metabolic syndrome (MetS) and lower urinary tract symptoms in postmenopausal women attending menopause clinic, to study the correlation of LUTS and body composition among women with MetS.Methods: 154 post-menopausal women who attended menopause clinic at the Christian Medical College Hospital Vellore, were recruited. MetS was diagnosed using IDF criteria. LUTS were assessed BFLUTS questionnaires. Blood was taken to assess serum fasting glucose and lipid proﬁle. DEXA was performed to assess the whole-body composition.Results: Of 154 postmenopausal women, 64% had MetS and 43% of women had a total LUTS score > 5. 90% of women had filling symptoms,57% had incontinence,17% had voiding symptoms,14 % had quality of life issues and 6 % had sexual symptoms. However, there was no statistical significant difference between two groups in correlating the variables of MetS with LUTS (P >0.05). The percentage of total body fat by DEXA scan was significantly greater (P=0.006) in women with MetS (37.32±5.04) when compared to the women without MetS (34.629±3.65).Conclusions: Prevalence of MetS among the study population was 64 %. LUTS were observed in 43% of the patients. There was no significant difference in LUTS in women with MetS and without Mets. However, there was a significant difference in body composition among women with and without MetS.

show abstract

A scored form of the Bristol Female Lower Urinary Tract Symptoms questionnaire: Data from a randomized controlled trial of surgery for women with stress incontinence

Cited by 238 publications

References 8 publications

INVESTIGATE-I (INVasive Evaluation before Surgical Treatment of Incontinence Gives Added Therapeutic Effect?): a mixed-methods study to assess the feasibility of a future randomised controlled trial of invasive urodynamic testing prior to surgery for stress urinary incontinence in women

INVESTIGATE-I (INVasive Evaluation before Surgical Treatment of Incontinence Gives Added Therapeutic Effect?): a mixed-methods study to assess the feasibility of a future randomised controlled trial of invasive urodynamic testing prior to surgery for stress urinary incontinence in women

Validation of Turkish Version of Bristol Female Lower Urinary Tract Symptom Index

Association of metabolic syndrome and lower urinary tract symptoms amongst South Indian postmenopausal women

Contact Info

Product

Resources

About